Europe Rosacea Market and Competitive Landscape – 2017

Lowest Prices Guaranteed	Publisher	Published Date	SKU
from $3,210	Fore Pharma	August, 2017	FPCI15450657

Lowest Prices Guaranteed
Price	from $3,210
Publisher	Fore Pharma
Published Date	August, 2017
SKU	FPCI15450657

PDF E-mail From Publisher:	$3,210
Global Site License Fulfilled by Publisher:	$5,010

Research assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Table of Contents
Description

Europe Rosacea Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Rosacea Market and Competitive Landscape – 2017, provides comprehensive insights into Rosacea pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Rosacea market size and drug sales. This research also provides insights into Rosacea epidemiology and late stage pipeline.
The report is classified into nine sections – Rosacea overview with definitions, symptoms, etiology, diagnosis, treatment options; Rosacea pipeline insights covering late stage clinical trials pipeline; Rosacea prevalence trends by countries; Rosacea market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

Rosacea pipeline: Find out the drugs in clinical trials for Rosacea by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
Rosacea epidemiology: Find out the prevalence of Rosacea by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
Rosacea products: Identify key products marketed and prescribed for Rosacea by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Rosacea market size: Find out the market size for Rosacea drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
Rosacea drug sales: Find out the sales of Rosacea drugs by countries – Europe, Germany, France, Italy, Spain, UK
Rosacea drugs sales forecast: Sales forecast for Rosacea drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Rosacea market share analysis: Find out the market shares of Rosacea drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

Evaluate commercial market opportunities for Rosacea drugs
Synthesize insights for business development & licensing
Track market size, competitor drug sales, market shares in Rosacea market
Develop in-depth knowledge of competition and markets
Analyze sales data to update your brand planning trackers
Develop tactics and strategies to take advantage of opportunities in the market
Track market trends and analyze key events in Rosacea market
Develop forecast models, healthcare frameworks, or economic models
Answer key business questions; supports decision making in R&D to long term marketing strategies

1. Rosacea: Disease Overview: 1.1. Rosacea Symptoms; 1.2. Rosacea Etiology; 1.3. Rosacea Diagnosis; 1.4. Rosacea Treatment Options
2. Rosacea Pipeline Insights: 2.1. Rosacea Phase 3 Clinical Trials; 2.2. Rosacea Phase 2 Clinical Trials; 2.3. Rosacea Phase 1 Clinical Trials
3. Rosacea Epidemiology Analysis
4. Germany Rosacea Market Insights: 4.1. Marketed Products for Rosacea in Germany; 4.2. Germany Rosacea Market Size & Forecast; 4.3. Germany Rosacea Product Sales Forecast; 4.4. Germany Rosacea Market Share Analysis
5. France Rosacea Market Insights: 5.1. Marketed Products for Rosacea in France; 5.2. France Rosacea Market Size & Forecast; 5.3. France Rosacea Product Sales Forecast; 5.4. France Rosacea Market Share Analysis
6. Italy Rosacea Market Insights: 6.1. Marketed Products for Rosacea in Italy; 6.2. Italy Rosacea Market Size & Forecast; 6.3. Italy Rosacea Product Sales Forecast; 6.4. Italy Rosacea Market Share Analysis
7. Spain Rosacea Market Insights: 7.1. Marketed Products for Rosacea in Spain; 7.2. Spain Rosacea Market Size & Forecast; 7.3. Spain Rosacea Product Sales Forecast; 7.4. Spain Rosacea Market Share Analysis
8. UK Rosacea Market Insights: 8.1. Marketed Products for Rosacea in UK; 8.2. UK Rosacea Market Size & Forecast; 8.3. UK Rosacea Product Sales Forecast; 8.4. UK Rosacea Market Share Analysis
9. Europe Rosacea Market Insights: 9.1. Europe Rosacea Market Size & Forecast; 9.2. Europe Rosacea Product Sales Forecast; 9.3. Europe Rosacea Market Share Analysis
10. Research Methodology
LIST OF TABLES: Table 1: Rosacea Phase 3 Clinical Trials, Global, 2017; Table 2: Rosacea Phase 2 Clinical Trials, Global, 2017; Table 3: Rosacea Phase 1 Clinical Trials, Global, 2017; Table 4: Rosacea Prevalence by EU5 Countries, 2012 - 2021; Table 5: Marketed Products for Rosacea in Germany, 2017; Table 6: Germany Rosacea Market Size & Forecast ($mn), 2012 - 2021; Table 7: Germany Rosacea Product Sales ($mn), 2012 - 2021; Table 8: Germany Rosacea Market Trends, 2012 - 2021; Table 9: Marketed Products for Rosacea in France, 2017; Table 10: France Rosacea Market Size & Forecast ($mn), 2012 - 2021; Table 11: France Rosacea Product Sales ($mn), 2012 - 2021; Table 12: France Rosacea Market Trends, 2012 - 2021; Table 13: Marketed Products for Rosacea in Italy, 2017; Table 14: Italy Rosacea Market Size & Forecast ($mn), 2012 - 2021; Table 15: Italy Rosacea Product Sales ($mn), 2012 - 2021; Table 16: Italy Rosacea Market Trends, 2012 - 2021; Table 17: Marketed Products for Rosacea in Spain, 2017; Table 18: Spain Rosacea Market Size & Forecast ($mn), 2012 - 2021; Table 19: Spain Rosacea Product Sales ($mn), 2012 - 2021; Table 20: Spain Rosacea Market Trends, 2012 - 2021; Table 21: Marketed Products for Rosacea in UK, 2017; Table 22: UK Rosacea Market Size & Forecast ($mn), 2012 - 2021; Table 23: UK Rosacea Product Sales ($mn), 2012 - 2021; Table 24: UK Rosacea Market Trends, 2012 - 2021; Table 25: Europe Rosacea Market Size & Forecast ($mn), 2012 - 2021; Table 26: Europe Rosacea Product Sales ($mn), 2012 - 2021
LIST OF FIGURES: Figure 1: Rosacea Pipeline by Phase (%), Global, 2017; Figure 2: Rosacea Prevalence by EU5 Countries, 2012 - 2021; Figure 3: Germany Rosacea Market Size ($mn), 2012 - 2021; Figure 4: Germany Rosacea Product Sales ($mn), 2012 - 2021; Figure 5: Germany Rosacea Market Share by Products (%), 2016; Figure 6: Germany Rosacea Market - Future Market Share (%), 2021; Figure 7: France Rosacea Market Size ($mn), 2012 - 2021; Figure 8: France Rosacea Product Sales ($mn), 2012 - 2021; Figure 9: France Rosacea Market Share by Products (%), 2016; Figure 10: France Rosacea Market - Future Market Share (%), 2021; Figure 11: Italy Rosacea Market Size ($mn), 2012 - 2021; Figure 12: Italy Rosacea Product Sales ($mn), 2012 - 2021; Figure 13: Italy Rosacea Market Share by Products (%), 2016; Figure 14: Italy Rosacea Market - Future Market Share (%), 2021; Figure 15: Spain Rosacea Market Size ($mn), 2012 - 2021; Figure 16: Spain Rosacea Product Sales ($mn), 2012 - 2021; Figure 17: Spain Rosacea Market Share by Products (%), 2016; Figure 18: Spain Rosacea Market - Future Market Share (%), 2021; Figure 19: UK Rosacea Market Size ($mn), 2012 - 2021; Figure 20: UK Rosacea Product Sales ($mn), 2012 - 2021; Figure 21: UK Rosacea Market Share by Products (%), 2016; Figure 22: UK Rosacea Market - Future Market Share (%), 2021; Figure 23: Europe Rosacea Market Size ($mn), 2012 - 2021; Figure 24: Europe Rosacea Product Sales ($mn), 2012 - 2021; Figure 25: Europe Rosacea Market Share by Products (%), 2016; Figure 26: Europe Rosacea Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Europe Rosacea Market and Competitive Landscape – 2017

Share this report

Other tasks